Compounds > cyclohexanol
Page last updated: 2024-08-18

cyclohexanol and jzl 184

cyclohexanol has been researched along with jzl 184 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Björklund, E; Fowler, CJ; Nilsson, J; Norén, E1
Abdullah, R; Cravatt, BF; Kinsey, SG; Lichtman, AH; Ramesh, D; Selley, DE; Wise, LE1
Cipriano, M; Fowler, CJ; Gouveia-Figueira, S; Nording, M; Persson, E1
Bagci, S; Dogrul, A; Gulsen, M; Ilkaya, F; Sakin, YS; Seyrek, M; Ulas, UH1
Bedse, G; Gaulden, AD; Hartley, ND; Kingsley, PJ; Marnett, LJ; Neale, E; Patel, S; Patrick, TA; Plath, N; Uddin, MJ1

Other Studies

5 other study(ies) available for cyclohexanol and jzl 184

ArticleYear
Inhibition of monoacylglycerol lipase by troglitazone, N-arachidonoyl dopamine and the irreversible inhibitor JZL184: comparison of two different assays.
    British journal of pharmacology, 2010, Volume: 161, Issue:7

    Topics: Animals; Arachidonic Acids; Benzodioxoles; Cannabinoid Receptor Modulators; Chromans; Cyclohexanols; Dopamine; Enzyme Assays; Glycerides; Humans; Monoacylglycerol Lipases; Nitrophenols; Piperidines; PPAR gamma; Rats; Rats, Sprague-Dawley; Rats, Wistar; Thiazolidinediones; Troglitazone

2010
Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects.
    The Journal of pharmacology and experimental therapeutics, 2013, Volume: 345, Issue:3

    Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arachidonic Acids; Benzodioxoles; Brain Chemistry; Cyclohexanols; Diclofenac; Dose-Response Relationship, Drug; Dronabinol; Drug Tolerance; Endocannabinoids; Glycerides; Guanosine 5'-O-(3-Thiotriphosphate); Male; Mice; Mice, Inbred C57BL; Monoacylglycerol Lipases; Pain Measurement; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Stomach Ulcer; Substance Withdrawal Syndrome; Substance-Related Disorders

2013
The influence of monoacylglycerol lipase inhibition upon the expression of epidermal growth factor receptor in human PC-3 prostate cancer cells.
    BMC research notes, 2014, Jul-10, Volume: 7

    Topics: Arachidonic Acids; Benzodioxoles; Cannabinoids; Cell Line, Tumor; Cell Proliferation; Cyclohexanols; Endocannabinoids; Enzyme Inhibitors; ErbB Receptors; Ethanolamines; Gene Expression Regulation, Neoplastic; Glycerides; Humans; Male; Monoacylglycerol Lipases; Piperidines; Polyunsaturated Alkamides; Prostate; Receptor, Cannabinoid, CB1; Signal Transduction

2014
The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents.
    Neurogastroenterology and motility, 2015, Volume: 27, Issue:7

    Topics: Amidohydrolases; Animals; Benzodioxoles; Carbamates; Colon; Cyclohexanols; Inflammation; Male; Mice; Mice, Inbred BALB C; Monoacylglycerol Lipases; Pain Measurement; Piperazines; Piperidines; Pyridines; Rats; Rats, Sprague-Dawley; Visceral Pain

2015
Functional Redundancy Between Canonical Endocannabinoid Signaling Systems in the Modulation of Anxiety.
    Biological psychiatry, 2017, Oct-01, Volume: 82, Issue:7

    Topics: Adaptation, Ocular; Animals; Anti-Anxiety Agents; Anxiety; Arachidonic Acids; Benzodioxoles; Brain; Cannabinoid Receptor Agonists; Cyclohexanols; Disease Models, Animal; Dronabinol; Endocannabinoids; Excitatory Postsynaptic Potentials; Glycerides; Heterocyclic Compounds, 1-Ring; Locomotion; Male; Mice; Mice, Inbred ICR; Piperidines; Polyunsaturated Alkamides; Pyridines; Signal Transduction

2017